Shanghai No.1 Pharmacy Co Ltd operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai No.1 Pharmacy Co Ltd with three other
drug stores in Asia:
Apex Healthcare Bhd
sales of 581.27 million Malaysian Ringgits [US$149.39 million]
of which 94%
was Wholesale and Distribution),
Sapporo Clinical Laboratory Inc.
(17.53 billion Japanese Yen [US$163.89 million]
of which 63%
was Dispensing Pharmacy Business), and
Medical Ikkou Co Ltd
based in Japan
(29.31 billion Japanese Yen [US$274.01 million]
of which 80%
During the year ended December of 2016, sales at
Shanghai No.1 Pharmacy Co Ltd were 1.52 billion Chinese Renmimbi (US$241.57 million).
a very small
increase of 1.9%
versus 2015, when the company's sales were 1.49 billion Chinese Renmimbi.
This was the third consecutive year of growth at Shanghai No.1 Pharmacy Co Ltd.
Sales of Other Operation saw an increase
that was more than double the company's growth rate: sales were up
9.8% in 2016, from
51.76 million Chinese Renmimbi to 56.85 million Chinese Renmimbi.
Shanghai No.1 Pharmacy Co Ltd also saw significant increases in sales in
Wholesale Trade (up 4.1% to 798.67 million Chinese Renmimbi)
Not all segments of Shanghai No.1 Pharmacy Co Ltd experienced an increase in sales in 2016:
sales of Pharmaceutical and Medicinal fell 1.3% to 663.51 million Chinese Renmimbi.